Cellular Characteristics of Acute Myeloblasts Leukemia Associated with t(8;21)(q22;q22)

References

• First MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Cancer Genet. Cytogenet. 1986; 23: 189–197
   PubMed Web of Science ®Google Scholar
• Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genet. Cytogenet. 1988; 30: 1–15
   PubMed Web of Science ®Google Scholar
• Rowley J. D. Identification of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann. Genet. 1973; 16: 109–112
   PubMedGoogle Scholar
• Kamada N., Okada K., Oguma N., Tanaka R., Mikami M., Uchino H. C-G translocation in acute myelocytic leukemia with low neutrophil alkaline phosphatase activity. Cancer 1976; 37: 2380–2387
   PubMed Web of Science ®Google Scholar
• Trujillo J. M., Cork A., Ahearm M. J., Youness E. L., McCredie K. B. Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. Blood 1979; 53: 695–706
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia, 1982. Translocation (8;21) (q22;q22) in acute nonlymphocytic leukemia. Cancer Genet. Cytogenet 1984; 11: 284–287
   PubMedGoogle Scholar
• Swirsky D. M., Li Y. S., Mathews J. G., Flemans R. J., Rees J. K. H., Hayhoe F. G. J. 8;21 translocation in acute granulocytic leukaemia: cytogenetical, cytochemical and clinical features. Br. J. Haematol. 1984; 56: 199–213
   PubMed Web of Science ®Google Scholar
• Ishibashi T., Kimura H., Abe R., Matsuda S., Uchida T., Kariyone S. Involvement of eosinophils in leukemia: Cytogenetic study of eosinophilic colonies from acute myelogenous leukemia associated with translocation (8;21). Cancer Genet. Cytogenet. 1986; 22: 189–194
   PubMed Web of Science ®Google Scholar
• Koeffler H. P. Ayndromes of acute nonlymphocytic leukemia. Ann. Int. Med. 1987; 107: 748–758
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., FAB Cooperative Group. Proposed revised criteria for the classification of acute myeloblastic leukemia. Ann. Int. Med. 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Arthur D. C, Berger R., Golomb H. M., Swansbury G. J., Reeves B. R., Alimena G., Van DenBerghe H., Bloomfield C. D., de la Chapelle A., Dewald G. W., Garson O. M., Hagemeijer A., Kanako Y., Mitlman F., Pierre R. V., Ruutu T., Sakurai M., Lawler S. D., Rowley J. D. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet. Cytogenet. 1989; 40: 203–216
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Jannossy G. Pattern of gene expression and the cellular origins of human leukemia. Biochem. Biophys. Acta. 1978; 516: 193–230
   PubMed Web of Science ®Google Scholar
• Foon K. A., Todd R. F., III. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Griffin D. J., Ritz J., Nadler L. M., Schlossman S. F. Expression of myeloid differentiation antigens on normal and myeloid cells. J. Clin. Invest. 1982; 68: 932–941
   Web of Science ®Google Scholar
• Civin C. I., Strayss L. C, Brovall C., Fackler M. J., Schwartz J. F., Shaper J. H. Antigenic analysis of hematopoiesis: III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG1a cells. J. Immunol. 1984; 133: 157–165
   PubMed Web of Science ®Google Scholar
• Andrews R. G., Singer J. W., Berstein L. D. Monoclonal antibody 12–8 recognized a 115-kd molecule present on both unipotent and multipotent hematopoietic colony forming cells and their precursors. Blood 1986; 67: 842–845
   PubMed Web of Science ®Google Scholar
• Caux C., Favre C., Saeland S., Duvert V., Mannoni P., Durand I., Aurbey J. P., de Vries J. E. Sequential loss of CD34 and class II MHC antigen on purified cord blood hematopoietic progenitors cultured with IL-3: characterization of CD34-, HLA-DR+ cells. Blood 1989; 74: 1287–1294
   PubMed Web of Science ®Google Scholar
• Nagasaka M., Maeda S., Maeda H., Chen H., Kita K., Mabuchi O., Misu H., Matsuo T., Sugiyama T. Four cases of t(4;l 1) acute leukemia and its myelomonocytic nature in infant. Blood 1983; 61: 1174–1181
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Maseki N., Takasaki N., Sakurai M., Hay-Ashi Y., Nakazawa S., Mori T., Sakurai M., Takeda T., Shikano T., Hiyoshi Y. Clinical and hematologic characteristics in acute leukemia with 11q23 translocations. Blood 1986; 67: 484–491
   PubMed Web of Science ®Google Scholar
• Tachibana N., Raimondi S. C, Lauser S. J., Sartain P., Dow L. W. Evidence for multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1987; 70: 1458–1461
   PubMed Web of Science ®Google Scholar
• Francesconi D., Pasquali F. 8/21 translocation, loss of the Y chromosome and Philadelphia chromosome. Br. J. Haematol. 1978; 38: 149–150
   PubMed Web of Science ®Google Scholar
• DeCuia M. R., Alimena G., Gastaldi R., Spiriti M. A. A., Giona F., Mancini M., Mandelli F. Acute myeloblasts leukemia with t(8;21) following Philadelphia positive acute lymphoblastic leukemia. Leukaemia 1989; 3: 310–313
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Raimondi S. C, Behm F. G., Santana V. M., Kalwinsky D. K., Pui C. H., Miro J. J., Williams D. L. Two karyotypically independent leukemic clones with the t(8;21) and 11q23 translocation in acute myeloblasts leukemia at relapse. Blood 1989; 73: 1650–1655
   PubMed Web of Science ®Google Scholar
• Janossy G., Coustan-Smith E., Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia 1989; 3: 170–181
   PubMed Web of Science ®Google Scholar
• Kita K., Nakase K., Miwa H., Masuya M., Nishii K., Morita N., Takaura N., Otsuji A., Shirakawa S., Ueda T., Nasu K., Kyo T., Dohy S., Kamada N. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD 19 together with stem cell antigen CD34. Blood 1992; 80: 470–477
   PubMed Web of Science ®Google Scholar
• Parreira A., Pombo de Oliveira M. S., Matutes E., Foroni L., Morilla R., Catovsky D. Terminal deoxynu-cleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia. Br. J. Haematol. 1988; 69: 219–224
   PubMed Web of Science ®Google Scholar
• Hurwitz C. A., Ramimondi S. C, Head D., Krance R., Mirro J., Kalwinsky D. K., Ayers G. D., Behm F. G. Distinct immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 1992; 80: 3182–3188
   PubMed Web of Science ®Google Scholar
• Nadler L. M., Korsmeyer S. J., Anderson K. C, Boyd A. W., Slaugenhoupt B., Park Jensen E., Coral F., Mayer R. J., Sallan S. E., Ritz J., Shlossman S. F. B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J. Clin. Invest. 1984; 74: 332–340
   PubMed Web of Science ®Google Scholar
• Osier W., Konig K., Ludwig W. D., Ganser A., Lind-Mann A., Mertelsmann R., Herrmann F. Incidence of lineage promiscuity in acute myeloblastic leukemia: Diagnostic implications of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping. Leukemia Res. 1988; 12: 887–895
   PubMed Web of Science ®Google Scholar
• Bradstock K. F., Kirk J., Grimsley P. G., Karbral A., Hughes W. G. Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations. Br. J. Haematol. 1989; 72: 512–518
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Larese A., Mazet L., Bougeot J. P., Ehrsam A., Fiere D. Expression of CD19 antigen on acute monoblastic leukemia cells at diagnosis and after TPA-induced differentiation. Leukemia Res. 1988; 12: 369–372
   PubMed Web of Science ®Google Scholar
• Smith L. J., Curtis J. E., Messner H. A., Senn J. S., Furthmayr H., McCulloch E. A. Lineage infidelity in acute leukemia. Blood 1983; 61: 1138–1145
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Chan L. C, Furley A. J. W., Watt S. M., Molgaad H. V. Lineage promiscuity in hematopoietic differentiation and leukemia. Blood 1986; 67: 1–11
   PubMed Web of Science ®Google Scholar
• Chen S. J., Flandrin G., Daniel M. T., Valensi F., Bar-Anger L., Grausz D., Berheim A., Chen Z., Sigaux F., Berger R. Philadelphia-positive acute leukemia: lineage promiscuity and inconsistently rearranged breakpoint cluster region. Leukemia 1988; 2: 261–273
   PubMed Web of Science ®Google Scholar
• Tax L. V., Bai Y., Pegram S., Capel P., Greaves M. F. A monoclonal antibody (WT1) for detecting leu-kemias of T-cell precursors (T-ALL). Blood 1983; 62: 1108–113
   PubMed Web of Science ®Google Scholar
• Cross A. H., Goorha R. M., Nuss R., Behm F. G., Murphy S. B., Kalwinsky D. K., Rammondi S., Kitching-Mann G. R., Mirro J. Acute myeloid leukemia with T-lymphoid features: A distinct biologic and clinical entity. Blood 1988; 72: 579–587
   PubMed Web of Science ®Google Scholar
• Lo Coco F., De Rossi G., Pasqualetti D., Lopez M., Diverio D., Latagliata R., Fenu S., Mandelli F. CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity. Br. J. Haematol. 1989; 73: 480–485
   PubMed Web of Science ®Google Scholar
• Kita K., Miwa H., Nakase K., Kawakami K., Kobayashi T., Shirakawa S., Tanaka I., Ohta C., Tsutani H., Oguma S., Kyo T., Dohy H., Kamada N., Nasu K., Uchino H. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993; 81: 2399–2405
   PubMed Web of Science ®Google Scholar
• Zutter M. M., Martin P. J., Hanke D., Kidd P. CD7+ acute non-lymphocytic leukemia: Evidence for an early multipotential progenitor. Leukemia Res. 1990; 14: 23–26
   PubMed Web of Science ®Google Scholar
• Sutherland D. R., Rudd C. E., Greaves M. F. Isolation and characterization of a human T lymphocyte associated glycoprotein (gp40). J. Immunol. 1984; 133: 327–333
   PubMed Web of Science ®Google Scholar
• Lobach D. F., Hensley L. L., Ho W., Haynes B. F. Ontogeny of human T cell antigens. Leukeocyte Typing II, E. L. Reinherz, B. F. Haynes, L. M. Nadler, I. D. Bernstein. Springer-Verlag, Inc., New York 1985; vol. 2: 397–406
   Google Scholar
• Kurtzberg J., Waldmann T. A., Davey M. P., Binger S. H., Moore J. O., Hershfield M. S., Haynes B. F. CD7+, CD4-, CD8- acute leukemia: A syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1989; 73: 381–390
   PubMed Web of Science ®Google Scholar
• Ema H., Kitano K., Suda T., Sato T., Muroi K., Ohta M., Yoshida M., Sakamoto S., Eguchi M., Miura Y. In vitro differentiation of leukemia cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21) (q22;q22). Blood 1990; 75: 350–356
   PubMed Web of Science ®Google Scholar
• Seiff C. A. Hematopoietic growth factors. J. Clin. Invest. 1987; 79: 1549–1557
   PubMed Web of Science ®Google Scholar
• Metcalf D. The molecular control of cell division, differentiation commitment and maturation in hematopoietic cells. Nature 1990; 339: 27–30
   Web of Science ®Google Scholar
• Kitamura T., Sato N., Arai K.-I., Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared subunit for the human IL-3 and GM-CSF receptors. Cell 1991; 66: 1165–1174
   PubMed Web of Science ®Google Scholar
• Tavemier J., Devos R., Cornells S., Tuypens T., Van der Hyden J., Fiers W., Plaetinck G. A human high affinity interleukin-5 receptor (IL-5R) is composed of an IL-5 specific α chain and α β chain shared with the receptor for GM-CSF. Cell 1991; 66: 1175–1184
   PubMed Web of Science ®Google Scholar
• Gao J., Erickson P., Gardiner K., Le Beau M. M., Diaz M. O., Patterson D., Rowly J. D., Drabkin H. A. Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogenous leukemia. Proc. Natl. Acad. Sci. USA 1991; 88: 488–4886
   Google Scholar
• Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene. AML1. Proc. Natl. Acad. Sci. USA 1991; 88: 10431–10434
   PubMed Web of Science ®Google Scholar
• Erickson P., Gao J., Chang K.-S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowly J., Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophia segmentation gene. Runt. Blood 1992; 80: 1825–1831
   PubMed Web of Science ®Google Scholar
• Maseki N., Miyoshi H., Shimizu K., Homma C., Ohki M., Sakurai M., Kaneko Y. The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood 1993; 81: 1573–1579
   PubMed Web of Science ®Google Scholar
• Tighe J. E., Daga A., Calabi F. Translocation breakpoints are clustered on both chromosome 8 and chromosome 21 in the t(8;21) of acute myeloid leukemia. Blood 1993; 81: 592–596
   PubMed Web of Science ®Google Scholar
• Nucifora G., Birn D. J., Erikson P., Gao J., LeBeau M. M., Drabkin H. A., Rowly J. D. Detection of DNA rearrangements in the AMLI and ETO loci and of and AMLI/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 1993; 81: 883–888
   PubMed Web of Science ®Google Scholar
• Daga A., Tighe J. E., Calabi F. Leukemia/Dro-sophia homology. Nature 1992; 356: 484
   PubMed Web of Science ®Google Scholar
• Duffy J. B., Gergen J. P. The Drosophia segmentation gene runt acts as a position-specific numerator element necessary for the uniform expression of the sex-determining gene Sex-lethal. Gene Dev. 1991; 5: 2176–2187
   PubMed Web of Science ®Google Scholar